IMIPENEM/CILASTATINE ARROW 500 mg/500 mg, powder for solution for infusion bottle
Active ingredients: Cilastatin, Cilastatin sodium, IMIPÉNEM ANHYDRE, Imipenem hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IMIPENEM/CILASTATINE ARROW 500 mg/500 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- EUGIA PHARMA (MALTA) (MALTE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Dec 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62866789CIP73006005CIP133400930060056Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMIPÉNEM MONOHYDRATÉpoudre | — | SA |
| CILASTATINE SODIQUEpoudre | — | SA |
| IMIPÉNEM ANHYDREpoudre | 500 mg · un flacon | FT |
| CILASTATINEpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.